OHA
EBS icon

Oak Hill Advisors’s Emergent Biosolutions EBS Stock Holding History

Oak Hill Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.24M Sell
1,113,338
-2,500,000
-69% -$25.9M 1.05% 8
2025
Q4 		$44.7M Hold
3,613,338
– – 7.29% 3
2025
Q3 		$16.6M Hold
3,613,338
– – 3.45% 5
2025
Q2 		$10.9M Buy
3,613,338
+2,500,000
+225% +$14.3M 2.74% 5
2025
Q1 		$5.41M Hold
1,113,338
– – 1.15% 9
2024
Q4 		$10.6M Hold
1,113,338
– – 1.96% 6
2024
Q3 		$9.3M Buy
+1,113,338
New +$10.1M 1.39% 6

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Oak Hill Advisors's EBS Position: Q1 2026 in Review

Oak Hill Advisors reduced its Emergent Biosolutions (EBS) stake by 69% in Q1 2026, selling an estimated $25.9M and leaving 1,113,338 shares worth $9.24M. The position accounts for 1.05% of the portfolio, ranked #8.

Oak Hill Advisors first reported a position in EBS in Q3 2024 and has held it in 7 quarters since. The position peaked at $44.7M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Oak Hill Advisors held 1,113,338 shares of Emergent Biosolutions worth $9.24M as of Q1 2026.
  • Oak Hill Advisors sold 2,500,000 Emergent Biosolutions shares in Q1 2026, an estimated $25.9M.
  • Emergent Biosolutions made up 1.05% of Oak Hill Advisors's portfolio in Q1 2026, its #8 holding.
  • Oak Hill Advisors first reported a position in Emergent Biosolutions in Q3 2024 and has held it in 7 quarters since.
  • Oak Hill Advisors's Emergent Biosolutions position peaked at $44.7M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Oak Hill Advisors's 13F filing for Q1 2026, filed 15 May 2026.